Following Its Recent Approval from Health Canada for the Relief of Neuropathy Pain, Innovus Pharma Announces Receipt of Notification to Commercialize Diabasens® in the European Union
InnovAge Holding Corp. (INNV)
NASDAQ:AMEX Investor Relations:
innovuspharma.com
Company Research
Source: Business Wire
Represents the Fourth Innovus Pharma Product Notification in the E.U. SAN DIEGO--(BUSINESS WIRE)-- Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced that it has received the CPNP notification number required to commercialize Diabasens® in all 28 member countries of the European Union. This represents the fourth Innovus Pharma product to receive CPNP notification in the European Union in the last few years, the others being for Zestra®, Zestra Glide® and Sensum+®. The product will be available as an over-the-counter (“OTC”) or behind the counter product and does not require a prescription. “We are pleased to announce the re
Show less
Read more
Impact Snapshot
Event Time:
INNV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INNV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INNV alerts
High impacting InnovAge Holding Corp. news events
Weekly update
A roundup of the hottest topics
INNV
News
- InnovAge Holding Corp. (NASDAQ: INNV) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $5.00 price target on the stock.MarketBeat
- InnovAge offers all-inclusive care center that nurtures passions for seniors in Philadelphia [CBS News]CBS News
- InnovAge Celebrates 35 Years of Transforming Senior Care [Yahoo! Finance]Yahoo! Finance
- InnovAge Celebrates 35 Years of Transforming Senior CareGlobeNewswire
- InnovAge Holding Corp (INNV) Q1 2025 Earnings Call Highlights: Revenue Surge and Operational ... [Yahoo! Finance]Yahoo! Finance
INNV
Earnings
- 11/5/24 - In-Line
INNV
Sec Filings
- 12/6/24 - Form 8-K
- 12/3/24 - Form 4
- 11/13/24 - Form SC
- INNV's page on the SEC website